![Graphic with a yellow background. In the middle of the graphic is an image of a female medical professional holding a clipboard with CDER on a piece of paper she's viewing on the clipboard. To the left and right of the woman are medical-specific icon bubbles. They include an icon of a magnifying glass, prescription bottle, line chart and DNA helix.](https://public4.pagefreezer.com:443/content/FDA/10-09-2023T13:24/https://www.fda.gov/files/styles/medium_3/public/Video%20Series%20Graphic.png?itok=RP2UjFAL)
New video series kicks off with an introduction on how we regulate drugs
Learn how we use science and data to ensure their safety, quality and efficacy
Learn how we use science and data to ensure their safety, quality and efficacy
Taking precautions for storing medications and supplies is key to being prepared
Agency reflects on progress, ongoing challenges in overdose prevention
We will discuss many aspects of electronic drug registration and listing
Experts will review currently accepted surrogate endpoints for NASH/MASH
Learn key mechanisms you can use to facilitate generic drug development
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.